Pervasiveness of HLA allele-specific expression loss across tumor types

Overview of attention for article published in Genome Medicine, February 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 22 X posts from 18 X users, with an upper bound of 90,210 followers.

RT @NCIsysbio: In a study supported by @Columbia #NCICSBC, @IoanFilip9, @KenOliveLab, et al. developed arcasHLA-quant, which revealed that…

RT @NCIsysbio: In a study supported by @Columbia #NCICSBC, @IoanFilip9, @KenOliveLab, et al. developed arcasHLA-quant, which revealed that…

RT @NCIsysbio: In a study supported by @Columbia #NCICSBC, @IoanFilip9, @KenOliveLab, et al. developed arcasHLA-quant, which revealed that…

In a study supported by @Columbia #NCICSBC, @IoanFilip9, @KenOliveLab, et al. developed arcasHLA-quant, which revealed that HLA-I allele-specific expression loss is associated with poor #immunotherapy outcomes in #melanoma @GenomeMedicine https://t.co/xtrj

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.